Catheter-associated infections, including catheter-associated urinary tract infections (CAUTIs) and central line-associated bloodstream infections (CLABSIs), represent a significant portion of HAIs. These infections can lead to severe complications, prolonged hospital stays, and increased healthcare costs. Antimicrobial catheters are designed to combat this issue by inhibiting the growth of bacteria and other microbes on the catheter surface, thereby reducing the risk of infection transmission.
